Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Michael O'Riordan

March 04, 2025

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Daily News

FDA Scolds Abiomed for Not Seeking a PMA for Its Web-Based User Portal

Caitlin E. Cox

October 17, 2023

News Conference News ESC 2023

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

Caitlin E. Cox

August 26, 2023

News Daily News

Label for Impella RP Flex Catheters Recalled to Address Anticoagulant Confusion: FDA

Caitlin E. Cox

August 18, 2023

News Conference News EuroPCR 2023

Registry Data Support TAVI in AS Patients With Cardiogenic Shock

Caitlin E. Cox

May 16, 2023

News Daily News

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

Michael O'Riordan

January 30, 2023

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

Caitlin E. Cox

November 06, 2022

News Daily News

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

Caitlin E. Cox

October 20, 2022

News Conference News TCT 2022

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

Shelley Wood

September 18, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Daily News

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

Shelley Wood

August 11, 2022

News Daily News

Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

Caitlin E. Cox

July 20, 2022

News Conference News THT 2022

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

Caitlin E. Cox

February 07, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Daily News

SCAI SHOCK: Update Refines Cardiogenic Shock Classification

Caitlin E. Cox

January 31, 2022

Advertisement

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Little Pre- and Postmarket Testing for Most Recalled CV Devices

FDA Scolds Abiomed for Not Seeking a PMA for Its Web-Based User Portal

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

Label for Impella RP Flex Catheters Recalled to Address Anticoagulant Confusion: FDA

Registry Data Support TAVI in AS Patients With Cardiogenic Shock

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

Many STEMI Patients Not Treated Within National Time Goals

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

SCAI SHOCK: Update Refines Cardiogenic Shock Classification

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content